Literature DB >> 8978695

A T cell controlled molecular pathway regulating the IgH locus: CD40-mediated activation of the IgH 3' enhancer.

P A Grant1, T Andersson, M F Neurath, V Arulampalam, A Bauch, R Müller, M Reth, S Pettersson.   

Abstract

Immunoglobulin heavy chain (IgH) class switch recombination and regulation of IgH expression levels are processes suggested to be controlled by the IgH 3' enhancer. Here we demonstrate that CD40 or IgM receptor stimulation of primary B cells results in transactivation of this enhancer. 4-Hydroxy-3-nitrophenylacetyl (NIP)-BSA induction of a K46 B cell line expressing a chimeric NIP-specific CD40 single chain receptor results in a ligand receptor-dependent response of a 3' enhancer ETS/AP-1 minimal promoter construct. Gel retardation analysis and genomic footprinting experiments reveal that CD40 or IgM induction recruits NFAB (nuclear factors of activated B cells) to the ETS/AP-1 motif. While IgM signalling recruits c-Fos, JunB and Elf-1 (NFAB-I), only JunB and Elf-1 were observed following CD40 signalling (NFAB-II). CD40 signalling, however, induces a Fos family-related partner for JunB, which may account for the transcriptional activity observed by NFAB-II in K46 cells. We propose a model whereby CD40 and IgM receptor-mediated signalling converge in the process of 3' enhancer activation in B lymphocytes. Our data provide a putative molecular explanation as to why CD40L-deficient mice, and possibly patients with hyper-IgM syndrome, are unable to undergo T cell-dependent class switch recombination but respond properly upon lipopolysaccharide-induced switch recombination.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8978695      PMCID: PMC452493     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  68 in total

Review 1.  Primary response genes induced by growth factors and tumor promoters.

Authors:  H R Herschman
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

2.  Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM.

Authors:  R Fuleihan; N Ramesh; R Loh; H Jabara; R S Rosen; T Chatila; S M Fu; I Stamenkovic; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

3.  Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain.

Authors:  P Sassone-Corsi; L J Ransone; W W Lamph; I M Verma
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

4.  Stimulation of B-cell proliferation by membrane-associated molecules from activated T cells.

Authors:  A A Brian
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

5.  Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the Pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny.

Authors:  F M Uckun; G L Schieven; I Dibirdik; M Chandan-Langlie; L Tuel-Ahlgren; J A Ledbetter
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

6.  CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.

Authors:  J P DiSanto; J Y Bonnefoy; J F Gauchat; A Fischer; G de Saint Basile
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

7.  Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins.

Authors:  K Kovary; R Bravo
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

8.  Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos-cJun heterodimers.

Authors:  R Turner; R Tjian
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

9.  Lipopolysaccharide-dependent transactivation of the temporally regulated immunoglobulin heavy chain 3' enhancer.

Authors:  V Arulampalam; P A Grant; A Samuelsson; U Lendahl; S Pettersson
Journal:  Eur J Immunol       Date:  1994-07       Impact factor: 5.532

10.  Immunoglobulin gene transcription ceases upon deletion of a distant enhancer.

Authors:  R Lieberson; J Ong; X Shi; L A Eckhardt
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  4 in total

1.  In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.

Authors:  Yi Yan; Sung Sup Park; Siegfried Janz; Laurel A Eckhardt
Journal:  Genes Chromosomes Cancer       Date:  2007-10       Impact factor: 5.006

2.  Burkitt lymphoma in the mouse.

Authors:  A L Kovalchuk; C F Qi; T A Torrey; L Taddesse-Heath; L Feigenbaum; S S Park; A Gerbitz; G Klobeck; K Hoertnagel; A Polack; G W Bornkamm; S Janz; H C Morse
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

3.  Class switching in B cells lacking 3' immunoglobulin heavy chain enhancers.

Authors:  J P Manis; N van der Stoep; M Tian; R Ferrini; L Davidson; A Bottaro; F W Alt
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

4.  LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.

Authors:  HaiDan Liu; Hui Zheng; Zhi Duan; DuoSha Hu; Ming Li; SuFang Liu; ZiJian Li; XiYun Deng; ZhenLian Wang; Min Tang; Ying Shi; Wei Yi; Ya Cao
Journal:  Mol Cancer       Date:  2009-10-27       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.